{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:39:14Z","timestamp":1791920354622,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejmech.2021.113253","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:49:51Z","timestamp":1612489791000},"page":"113253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-2390","authenticated-orcid":false,"given":"William","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline G.","family":"Dans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-6791","authenticated-orcid":false,"given":"Maria R.","family":"Gancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2814-1193","authenticated-orcid":false,"given":"Sandra","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania F.","family":"de Koning-Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym N.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene Jousset","family":"Sabroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-1405","authenticated-orcid":false,"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-6795","authenticated-orcid":false,"given":"Paul R.","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-1048","authenticated-orcid":false,"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40249-019-0524-x","article-title":"Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead","volume":"8","author":"Dhiman","year":"2019","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ejmech.2021.113253_bib2","series-title":"World Malaria Report","year":"2019"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-3-5","article-title":"History of the discovery of the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasites Vectors"},{"issue":"3 Suppl","key":"10.1016\/j.ejmech.2021.113253_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR Network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-resistant Plasmodium falciparum malaria","volume":"4","author":"Fairhurst","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2021.113253_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2018.06.003","article-title":"Mechanisms of artemisinin resistance in Plasmodium falciparum malaria","volume":"42","author":"Suresh","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113253_bib7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in\u00a0vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"issue":"23","key":"10.1016\/j.ejmech.2021.113253_bib9","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113253_bib10","series-title":"Global Technical Strategy for Malaria, 2016-2030","year":"2015"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/femsre\/fuw001","article-title":"Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria","volume":"40","author":"Beeson","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"issue":"32","key":"10.1016\/j.ejmech.2021.113253_bib12","doi-asserted-by":"crossref","first-page":"14378","DOI":"10.1073\/pnas.1009198107","article-title":"Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development","volume":"107","author":"Boyle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/femsre\/fuz005","article-title":"Targeting malaria parasite invasion of red blood cells as an antimalarial strategy","volume":"43","author":"Burns","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpara.2020.01.002","article-title":"Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds","volume":"50","author":"Dans","year":"2020","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.1501581","article-title":"Recruitment of Factor H as a novel complement evasion strategy for blood-stage Plasmodium falciparum infection","volume":"196","author":"Kennedy","year":"2016","journal-title":"J.\u00a0Immunol."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113253_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112571","article-title":"Plasmodium falciparum transfected with ultra bright NanoLuc luciferase offers high sensitivity detection for the screening of growth and cellular trafficking inhibitors","volume":"9","author":"Azevedo","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113253_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bmcl.2007.11.038","article-title":"Design, synthesis and antimalarial activity of benzene and isoquinoline sulfonamide derivatives","volume":"18","author":"Kumar Parai","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bmcl.2009.10.130","article-title":"Antiplasmodial activity of piperazine sulfonamides","volume":"20","author":"Martyn","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"7296","key":"10.1016\/j.ejmech.2021.113253_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.6b01673","article-title":"Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in\u00a0vivo activity","volume":"60","author":"Gilson","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12915-015-0162-0","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum","volume":"13","author":"Wilson","year":"2015","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejmech.2021.113253_bib25","series-title":"Compounds and Methods for Inhibiting JAK","author":"\u00c5strand","year":"2017"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113253_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0014-827X(99)00034-8","article-title":"In\u00a0vitro hepatic microsomal metabolism of N-benzyl-N-methylaniline","volume":"54","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"1999","journal-title":"Farmaco"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113253_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03190081","article-title":"Studies on thein\u00a0vitro hepatic microsomal formation of amides during the metabolism of certain secondary and tertiary benzylic amines","volume":"25","author":"\u00dclgen","year":"2000","journal-title":"Eur. J. Drug Metab. Pharmokinet."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113253_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF03190970","article-title":"In\u00a0vitro microsomal metabolism of nuclear chloro substituted secondary amines and imines","volume":"22","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"1997","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj0590159","article-title":"Studies in detoxication. 61. The metabolism of alkylbenzenes: tert.-butylbenzene","volume":"59","author":"Robinson","year":"1955","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113253_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/ml400045j","article-title":"Metabolically stable tert-butyl replacement","volume":"4","author":"Barnes-Seeman","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cmdc.201402502","article-title":"Evaluation of tert-butyl isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities","volume":"10","author":"Westphal","year":"2015","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113253_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bmcl.2006.10.044","article-title":"Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: a new use of silicon bioisosteres in medicinal chemistry","volume":"17","author":"Barnes","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"20","key":"10.1016\/j.ejmech.2021.113253_bib33","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1039\/b911483a","article-title":"Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine","volume":"7","author":"Wipf","year":"2009","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113253_bib34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.94.4.817","article-title":"A\u00a0primary human ventricular target of the nonsedating antihistamine Terfenadine","volume":"94","author":"Roy","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2021.113253_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12915-015-0162-0","article-title":"Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum","volume":"13","author":"Wilson","year":"2015","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib36","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1128\/AAC.01881-12","article-title":"Defining the timing of action of antimalarial drugs against Plasmodium falciparum","volume":"57","author":"Wilson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113253_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1475-2875-9-152","article-title":"Development of fluorescent Plasmodium falciparum for in\u00a0vitro growth inhibition assays","volume":"9","author":"Wilson","year":"2010","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113253_bib39","first-page":"5244","article-title":"Amplification of the multidrug resistance gene pfmdr1 in Plasmodium falciparum has arisen as multiple independent events","volume":"11","author":"Triglia","year":"1991","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In\u00a0vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2009","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113253_bib41","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/AAC.03265-14","article-title":"Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains","volume":"59","author":"Chugh","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113253_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.00079-12","article-title":"Human infections and detection of Plasmodium knowlesi","volume":"26","author":"Singh","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13071-017-2155-z","article-title":"The development of sexual stage malaria gametocytes in a Wave Bioreactor","volume":"10","author":"Demanga","year":"2017","journal-title":"Parasites Vectors"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2875-11-34","article-title":"Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?","volume":"11","author":"Peatey","year":"2012","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113253_bib45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nprot.2016.056","article-title":"Large-scale production of Plasmodium falciparum gametocytes for malaria drug discovery","volume":"11","author":"Duffy","year":"2016","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113253_bib46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113253_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the Medicines for Malaria Venture Pathogen Box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113253_bib48","doi-asserted-by":"crossref","first-page":"e01804","DOI":"10.1128\/AAC.01804-18","article-title":"Evaluation of 4-amino 2-anilinoquinazolines against Plasmodium and other apicomplexan parasites in\u00a0vitro and in a P.\u00a0falciparum humanized NOD-scid IL2R\u03b3(null) mouse model of malaria","volume":"63","author":"Gilson","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113253_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejmech.2018.05.022","article-title":"Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P(2) position of PEXEL peptidomimetics","volume":"154","author":"Nguyen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6220","key":"10.1016\/j.ejmech.2021.113253_bib50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"issue":"4254","key":"10.1016\/j.ejmech.2021.113253_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.ejmech.2021.113253_bib52","doi-asserted-by":"crossref","first-page":"14378","DOI":"10.1073\/pnas.1009198107","article-title":"Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development","volume":"107","author":"Boyle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113253_bib53","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acs.jmedchem.9b00462","article-title":"Identification of 5-substituted 2-acylaminothiazoles that activate Tat-mediated transcription in HIV-1 latency models","volume":"62","author":"Nguyen","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113253_bib54","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in\u00a0vitro half-life approach and non-specific binding to microsomes","volume":"27","author":"Obach","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113253_bib55","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/ac9912247","article-title":"A\u00a0high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates","volume":"72","author":"Bevan","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2021.113253_bib56","series-title":"Calculator Plugins Were Used for Structure Property Prediction and Calculation, MarvinSketch 6.0.6","year":"2013"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:01Z","timestamp":1759328701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":55,"alternative-id":["S0223523421001021"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113253","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113253"}}